CRISPR THERAPEUTICS AG (CRSP)

SEC filing

CRISPR THERAPEUTICS AG

CRSP · CIK 1674416

4 · Oct 16, 2026 · Director George Simeon sold 14.51K Common Shares at $49.63/unit ($720.4K); exercised options for 60K shares

Director George Simeon sold 14.51K Common Shares at $49.63/unit ($720.4K); exercised options for 60K shares

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).